https://study.yonapo.com/topics/pharmacology-y3/a1-cholinergic-and-adrenergic-transmission-and-its-presynaptic-modificationhttps://study.yonapo.com/topics/pharmacology-y3/a2-cholinomimeticshttps://study.yonapo.com/topics/pharmacology-y3/a3-muscarinic-receptor-blocking-drugshttps://study.yonapo.com/topics/pharmacology-y3/a4-catecholamineshttps://study.yonapo.com/topics/pharmacology-y3/a5-indirect-sympathomimetics-selective-1-agonistshttps://study.yonapo.com/topics/pharmacology-y3/a6-2-agonists-and-drugs-acting-on-the-imidazoline-receptorshttps://study.yonapo.com/topics/pharmacology-y3/a7-receptor-antagonistshttps://study.yonapo.com/topics/pharmacology-y3/a8-receptor-antagonistshttps://study.yonapo.com/topics/pharmacology-y3/a9-centrally-and-peripherally-acting-skeletal-muscle-relaxantshttps://study.yonapo.com/topics/pharmacology-y3/a10-local-anestheticshttps://study.yonapo.com/topics/pharmacology-y3/a11-opioidshttps://study.yonapo.com/topics/pharmacology-y3/a12-nsaidshttps://study.yonapo.com/topics/pharmacology-y3/a13-drugs-used-for-treatment-of-gout-drugs-for-headache-syndromeshttps://study.yonapo.com/topics/pharmacology-y3/a14-inhalational-anestheticshttps://study.yonapo.com/topics/pharmacology-y3/a15-intravenous-anesthetics-perioperative-medicationhttps://study.yonapo.com/topics/pharmacology-y3/a16-benzodiazepineshttps://study.yonapo.com/topics/pharmacology-y3/a17-non-benzodiazepine-anxiolytics-and-non-benzodiazepine-hypnoticshttps://study.yonapo.com/topics/pharmacology-y3/a18-antipsychoticshttps://study.yonapo.com/topics/pharmacology-y3/a19-monoamine-reuptake-inhibitorshttps://study.yonapo.com/topics/pharmacology-y3/a20-non-reuptake-inhibitor-antidepressants-agents-used-for-treatment-of-manic-phase-of-bipolar-disordershttps://study.yonapo.com/topics/pharmacology-y3/a21-antiepileptics-adjuvant-analgesicshttps://study.yonapo.com/topics/pharmacology-y3/a22-drugs-of-neurodegenerative-diseases-extrapyramidal-motoric-system-nootropic-drugshttps://study.yonapo.com/topics/pharmacology-y3/b1-drugs-influencing-blood-coagulation-i-antiplatelet-agents-fibrinolytic-drugs-drugs-inhibiting-bleedinghttps://study.yonapo.com/topics/pharmacology-y3/b2-drugs-influencing-blood-coagulation-ii-anticoagulant-drugshttps://study.yonapo.com/topics/pharmacology-y3/b3-agents-used-in-anemiashttps://study.yonapo.com/topics/pharmacology-y3/b4-positive-inotropic-drugshttps://study.yonapo.com/topics/pharmacology-y3/b5-drugs-influencing-cardiac-electrophysiologyhttps://study.yonapo.com/topics/pharmacology-y3/b6-drugs-acting-on-the-renin-angiotensin-aldosterone-system-raashttps://study.yonapo.com/topics/pharmacology-y3/b7-ca-channel-blockers-and-other-vasodilatorshttps://study.yonapo.com/topics/pharmacology-y3/b8-drugs-influencing-the-oxygen-demand-and-oxygen-supply-of-the-heart-drugs-improving-microcirculationhttps://study.yonapo.com/topics/pharmacology-y3/b9-drugs-affecting-lipid-metabolism-drugs-controlling-body-weighthttps://study.yonapo.com/topics/pharmacology-y3/b10-potassium-excreting-wasting-diureticshttps://study.yonapo.com/topics/pharmacology-y3/b11-potassium-sparing-diuretics-adh-antagonists-osmotic-diureticshttps://study.yonapo.com/topics/pharmacology-y3/b12-glucocorticoids-for-oral-and-parenteral-usehttps://study.yonapo.com/topics/pharmacology-y3/b13-mineralocorticoids-topically-applied-glucocorticoids-adrenocortical-antagonists-inhibitors-of-corticosteroid-synthesishttps://study.yonapo.com/topics/pharmacology-y3/b14-androgens-anabolic-steroids-antiandrogens-agents-affecting-the-sexual-activityhttps://study.yonapo.com/topics/pharmacology-y3/b15-estrogens-and-antiestrogenshttps://study.yonapo.com/topics/pharmacology-y3/b16-progestins-and-antiprogestins-contraceptiveshttps://study.yonapo.com/topics/pharmacology-y3/b17-thyroid-and-antithyroid-drugs-pituitary-hormones-hypothalamic-hormones-hormonanalogs-and-antagonistshttps://study.yonapo.com/topics/pharmacology-y3/b18-pancreatic-hormones-and-parenterally-applied-antidiabetic-drugshttps://study.yonapo.com/topics/pharmacology-y3/b19-oral-antidiabeticshttps://study.yonapo.com/topics/pharmacology-y3/b20-agents-affecting-bone-mineral-homeostasis-calcium-vitamin-d-parathyroid-hormone-calcitonin-etchttps://study.yonapo.com/topics/pharmacology-y3/b21-selective-2-stimulants-and-other-bronchodilatorshttps://study.yonapo.com/topics/pharmacology-y3/b22-antiinflammatory-agents-inhibiting-bronchial-inflammatory-processes-antitussive-agents-and-expectorantshttps://study.yonapo.com/topics/pharmacology-y3/b23-drugs-influencing-gastric-acid-secretion-protective-drugs-of-gastric-mucosahttps://study.yonapo.com/topics/pharmacology-y3/b24-antiemetic-drugs-prokinetic-agentshttps://study.yonapo.com/topics/pharmacology-y3/b25-drugs-used-in-constipation-laxatives-and-diarrhea-drugs-promoting-digestion-pharmacology-of-liver-and-biliary-tracthttps://study.yonapo.com/topics/pharmacology-y3/b26-histamine-and-antihistamineshttps://study.yonapo.com/topics/pharmacology-y3/b27-drugs-acting-on-smooth-muscles-drugs-influencing-uterus-contractionshttps://study.yonapo.com/topics/pharmacology-y3/b28-immunopharmacology-i-cytotoxic-agentshttps://study.yonapo.com/topics/pharmacology-y3/b29-immunopharmacology-ii-inhibitors-of-cytokine-gene-expression-5-asa-derivativeshttps://study.yonapo.com/topics/pharmacology-y3/b30-immunopharmacology-iii-antibodies-and-fusion-proteinshttps://study.yonapo.com/topics/pharmacology-y3/b31-drugs-used-in-cancer-treatment-i-antimetaboliteshttps://study.yonapo.com/topics/pharmacology-y3/b32-drugs-used-in-cancer-treatment-ii-cytotoxic-agents-targeting-dnahttps://study.yonapo.com/topics/pharmacology-y3/b33-drugs-used-in-cancer-treatment-iii-topoisomerase-inhibitors-inhibitors-of-mitotic-spindlehttps://study.yonapo.com/topics/pharmacology-y3/b34-drugs-used-in-cancer-treatment-iv-hormonal-agentshttps://study.yonapo.com/topics/pharmacology-y3/b35-drugs-used-in-cancer-treatment-v-small-molecule-signal-transduction-inhibitors-retinoidshttps://study.yonapo.com/topics/pharmacology-y3/b36-drugs-used-in-cancer-treatment-vi-large-molecule-signal-transduction-inhibitors-immunostimulant-anticancer-drugshttps://study.yonapo.com/topics/pharmacology-y3/c1-disinfectants-and-antisepticshttps://study.yonapo.com/topics/pharmacology-y3/c2-antimycobacterial-drugshttps://study.yonapo.com/topics/pharmacology-y3/c3-antiprotozoal-and-antihelminthic-drugshttps://study.yonapo.com/topics/pharmacology-y3/c4-antifungal-agentshttps://study.yonapo.com/topics/pharmacology-y3/c5-agents-to-treat-herpes-simplex-hsv-varicella-zoster-vzv-cytomegalovirus-cmv-anti-influenza-agents-drugs-against-corona-and-other-viruseshttps://study.yonapo.com/topics/pharmacology-y3/c6-antiretroviral-agentshttps://study.yonapo.com/topics/pharmacology-y3/c7-agents-against-hepatitis-viruseshttps://study.yonapo.com/topics/pharmacology-y3/c8-penicillinshttps://study.yonapo.com/topics/pharmacology-y3/c9-cephalosporinshttps://study.yonapo.com/topics/pharmacology-y3/c10-carbapenems-monobactams-beta-lactamase-inhibitorshttps://study.yonapo.com/topics/pharmacology-y3/c11-chloramphenicol-polymyxins-antifolate-drugshttps://study.yonapo.com/topics/pharmacology-y3/c12-tetracyclines-and-glycylcyclineshttps://study.yonapo.com/topics/pharmacology-y3/c13-aminoglycosideshttps://study.yonapo.com/topics/pharmacology-y3/c14-quinolones-and-fluoroquinoloneshttps://study.yonapo.com/topics/pharmacology-y3/c15-macrolides-pleuromutilinshttps://study.yonapo.com/topics/pharmacology-y3/c16-clindamycin-streptogramins-oxazolidinones-fusidanshttps://study.yonapo.com/topics/pharmacology-y3/c17-glycopeptides-lipopeptides-bacitracin-mupirocinhttps://study.yonapo.com/topics/pharmacology-y3/c18-metronidazole-fidaxomicin-rifaximin-nitrofurantoin-fosfomycinhttps://study.yonapo.com/topics/pharmacology-y3/core1-stages-of-drug-development-in-briefhttps://study.yonapo.com/topics/pharmacology-y3/core2-types-of-clinical-trialshttps://study.yonapo.com/topics/pharmacology-y3/core3-history-of-the-hungarian-pharmaceutical-industryhttps://study.yonapo.com/topics/pharmacology-y3/core4-molecular-targets-of-drugshttps://study.yonapo.com/topics/pharmacology-y3/core5-receptor-theory-agonist-partial-agonist-antagonist-inverse-agonisthttps://study.yonapo.com/topics/pharmacology-y3/core6-efficacy-potencyhttps://study.yonapo.com/topics/pharmacology-y3/core7-dose-effect-relationships-at-population-levelhttps://study.yonapo.com/topics/pharmacology-y3/core8-adverse-drug-reactionshttps://study.yonapo.com/topics/pharmacology-y3/core9-therapeutic-indexhttps://study.yonapo.com/topics/pharmacology-y3/core10-tolerance-tachyphylaxis-dependencehttps://study.yonapo.com/topics/pharmacology-y3/core11-absorption-of-drugshttps://study.yonapo.com/topics/pharmacology-y3/core12-membrane-transport-mechanismshttps://study.yonapo.com/topics/pharmacology-y3/core13-distribution-of-drugshttps://study.yonapo.com/topics/pharmacology-y3/core14-bioavailabilityhttps://study.yonapo.com/topics/pharmacology-y3/core15-volume-of-distributionhttps://study.yonapo.com/topics/pharmacology-y3/core16-phases-of-drug-biotransformationhttps://study.yonapo.com/topics/pharmacology-y3/core17-excretion-of-drugshttps://study.yonapo.com/topics/pharmacology-y3/core18-linear-and-non-linear-pharmacokineticshttps://study.yonapo.com/topics/pharmacology-y3/core19-clearancehttps://study.yonapo.com/topics/pharmacology-y3/core20-half-lifehttps://study.yonapo.com/topics/pharmacology-y3/core21-saturating-and-maintenance-dosehttps://study.yonapo.com/topics/pharmacology-y3/core22-drug-accumulation-and-cumulationhttps://study.yonapo.com/topics/pharmacology-y3/core23-enzyme-inducershttps://study.yonapo.com/topics/pharmacology-y3/core24-enzyme-inhibitorshttps://study.yonapo.com/topics/pharmacology-y3/core25-pharmacodynamic-interactions-synergismhttps://study.yonapo.com/topics/pharmacology-y3/core26-pharmacodynamic-interactions-antagonismhttps://study.yonapo.com/topics/pharmacology-y3/core27-pharmacokinetic-drug-interactions-at-the-level-of-absorptionhttps://study.yonapo.com/topics/pharmacology-y3/core28-pharmacokinetic-drug-interactions-at-the-level-of-distributionhttps://study.yonapo.com/topics/pharmacology-y3/core29-pharmacokinetic-drug-interactions-at-the-level-of-metabolismhttps://study.yonapo.com/topics/pharmacology-y3/core30-pharmacokinetic-drug-interactions-at-the-level-of-eliminationhttps://study.yonapo.com/topics/pharmacology-y3/core31-special-groups-drug-interactions-pregnancyhttps://study.yonapo.com/topics/pharmacology-y3/core32-special-groups-drug-interactions-childhoodhttps://study.yonapo.com/topics/pharmacology-y3/core33-special-groups-drug-interactions-ageinghttps://study.yonapo.com/topics/pharmacology-y3/core34-characterisation-of-biological-medicinal-productshttps://study.yonapo.com/topics/pharmacology-y3/core35-orphan-drugshttps://study.yonapo.com/topics/pharmacology-y3/core36-advanced-therapy-medicinal-products-vaccineshttps://study.yonapo.com/topics/pharmacology-y3/core37-nutritional-supplementshttps://study.yonapo.com/topics/pharmacology-y3/core38-traditional-herbal-active-substanceshttps://study.yonapo.com/topics/pharmacology-y3/core39-medical-devicehttps://study.yonapo.com/topics/pharmacology-y3/core40-principles-of-antimicrobial-treatment-selective-toxicityhttps://study.yonapo.com/topics/pharmacology-y3/core41-principles-of-antimicrobial-treatment-empirical-targeted-and-prophylactic-therapyhttps://study.yonapo.com/topics/pharmacology-y3/core42-principles-of-antimicrobial-treatment-bactericidal-bacteriostatic-antibiotics-and-antibiotic-combinationshttps://study.yonapo.com/topics/pharmacology-y3/core43-principles-of-antimicrobial-treatment-time-concentration-and-exposure-dependent-antibioticshttps://study.yonapo.com/topics/pharmacology-y3/core44-narrow-and-broad-spectrum-antibioticshttps://study.yonapo.com/topics/pharmacology-y3/core45-antibiotic-selection-considerations-pregnancy-childhoodhttps://study.yonapo.com/topics/pharmacology-y3/core46-antibiotic-selection-considerations-infections-affecting-specific-compartmentshttps://study.yonapo.com/topics/pharmacology-y3/core47-considerations-for-antibiotic-choice-comorbiditieshttps://study.yonapo.com/topics/pharmacology-y3/core48-antidote-definition-and-exampleshttps://study.yonapo.com/topics/pharmacology-y3/core49-pharmacogenetics-pharmacogenomics-definition-exampleshttps://study.yonapo.com/topics/pharmacology-y3/core50-classification-of-drugs-according-to-chemical-structure-and-complexityhttps://study.yonapo.com/topics/pharmacology-y3/core51-drug-induced-adverse-reaction-sulfonamide-allergy-and-its-characterizationhttps://study.yonapo.com/topics/pharmacology-y3/core52-drug-induced-adverse-reaction-serotonin-syndromehttps://study.yonapo.com/topics/pharmacology-y3/core53-drug-induced-adverse-reaction-neuroleptic-malignant-syndromehttps://study.yonapo.com/topics/pharmacology-y3/core54-drug-induced-adverse-reaction-stevens-johnson-syndromehttps://study.yonapo.com/topics/pharmacology-y3/core55-drug-induced-adverse-reaction-pseudomembranous-colitishttps://study.yonapo.com/topics/pharmacology-y3/core56-drug-induced-adverse-reaction-cheese-reactionhttps://study.yonapo.com/topics/pharmacology-y3/core57-drug-induced-adverse-reaction-orthostatic-hypotensionhttps://study.yonapo.com/topics/pharmacology-y3/core58-drug-induced-adverse-reaction-hemorrhagehttps://study.yonapo.com/topics/pharmacology-y3/core59-drug-induced-adverse-reaction-thrombosishttps://study.yonapo.com/topics/pharmacology-y3/core60-drug-induced-adverse-reaction-bone-marrow-damagehttps://study.yonapo.com/topics/pharmacology-y3/core61-drug-induced-adverse-reaction-nephrotoxicityhttps://study.yonapo.com/topics/pharmacology-y3/core62-drug-induced-adverse-reaction-ototoxicityhttps://study.yonapo.com/topics/pharmacology-y3/core63-drug-induced-adverse-reaction-hepatotoxicityhttps://study.yonapo.com/topics/pharmacology-y3/core64-drug-induced-adverse-reaction-qt-prolongationhttps://study.yonapo.com/topics/pharmacology-y3/core65-drug-induced-adverse-reaction-bradycardia-av-blockhttps://study.yonapo.com/topics/pharmacology-y3/core66-drug-induced-adverse-reaction-constipation-diarrhea-vomitinghttps://study.yonapo.com/topics/pharmacology-y3/core67-drug-induced-adverse-reaction-mucosal-damagehttps://study.yonapo.com/topics/pharmacology-y3/core68-drug-induced-adverse-reaction-weight-gain-losshttps://study.yonapo.com/topics/pharmacology-y3/core69-drug-induced-adverse-reaction-sedationhttps://study.yonapo.com/topics/pharmacology-y3/core70-drug-induced-adverse-reaction-epileptiform-seizureshttps://study.yonapo.com/topics/pharmacology-y3/core71-drug-induced-adverse-reaction-sexual-dysfunctionhttps://study.yonapo.com/topics/pharmacology-y3/core72-drug-induced-adverse-reaction-dental-and-oral-cavity-adverse-reactionshttps://study.yonapo.com/topics/pharmacology-y3/core73-the-summary-of-product-characteristics